Phoenix Local Business
Saturday, November 21, 2015
FDA Staff Skeptical of Muscular Dystrophy Drug Drisapersen
(MedPage Today) -- Agency questions clinical benefit
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment